title: The Dengue Vaccine Dilemma: Balancing the Individual and Population Risks and Benefits.
abstract: In a Perspective, Jacqueline Deeen discusses challenges in balancing the individual and population risks and benefits for CYD-TDV (Dengvaxia), the first available dengue vaccine.
authors.affiliation: Institute of Child Health and Human Development, National Institutes of Health, University of the Philippines, Manila, Philippines.
authors.forename: Jacqueline
authors.identifier: http://orcid.org/0000-0001-8875-5026
authors.initials: J
authors.lastname: Deen
mesh_terms: D003715:Dengue / Q000517:prevention & control*; D053059:Dengue Vaccines / Q000009:adverse effects / Q000592:standards*; D006801:Humans; D018570:Risk Assessment; D014611:Vaccination / Q000592:standards / Q000706:statistics & numerical data
chemical_list: D053059:Dengue Vaccines